Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial

BACKGROUND: Antipsychotic-induced Weight Gain (AiWG) is a debilitating and common adverse effect of antipsychotics. AiWG negatively impacts life expectancy, quality of life, treatment adherence, likelihood of developing type-2 diabetes and readmission. Treatment of AiWG is currently challenging, and...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Nini, Guloksuz, Sinan, van Baal, Caroline, Willebrands, Leonie, Deenik, Jeroen, Vinkers, Christiaan H., Rossum, Inge Winter-van, Zinkstok, Janneke, Wilting, Ingeborg, Zantvoord, Jasper B., Backx, Frank, Swildens, Wilma E., Schouw, Marieke, Bogers, Jan, Hulshof, Folkwin, de Knijff, Rudolf, Duindam, Peter, Veereschild, Mike, Bak, Maarten, Frederix, Geert, de Haan, Lieuwe, van Os, Jim, Cahn, Wiepke, Luykx, Jurjen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783702/
https://www.ncbi.nlm.nih.gov/pubmed/33402159
http://dx.doi.org/10.1186/s12888-020-02992-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783702/
https://www.ncbi.nlm.nih.gov/pubmed/33402159
http://dx.doi.org/10.1186/s12888-020-02992-4

Ejemplares similares